New York, NY (PRWEB) March 28, 2014
Androgel lawsuits (http://www.testosteronelawsuitcenter.com/androgel-lawsuit/) and other product liability claims involving low testosterone therapies continue to mount in courts around the country, Bernstein Liebhard LLP reports. According to court documents, the Executive Committee of the U.S. District Court, Northern District of Illinois, has ordered that all testosterone lawsuits filed in that district involving AndroGel be consolidated for coordinated pretrial proceedings. According to an Order dated March 14, 2014, the docket, which currently consists of at least 30 AndroGel lawsuits, will be assigned to U.S. District Judge Matthew F. Kennelly. (14 CV 1748, in re AbbVie , Inc., et al.)
“Our Firm has received numerous inquiries by men who allegedly suffered serious heart problems due to their use of AndroGel and other low testosterone therapies. Considering the potential for a large litigation, it would appear that the consolidation of the AndroGel lawsuits is warranted,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal reviews to anyone who may have suffered serious heart attacks, strokes, deep vein thrombosis or pulmonary embolism, allegedly due to the use of prescription testosterone therapies.
Testosterone Treatment Lawsuits
According to court documents, AndroGel lawsuits began to mount in courts around the country after the U.S. Food & Drug Administration (FDA) announced in January that it was reviewing the safety of low testosterone therapies. The FDA acted after two studies indicated the drugs might be associated with an increased risk of heart attacks, strokes and sudden cardiac death in certain men.
Court filings indicate that all of the complaints currently pending in the Northern District of Illinois claim that AndroGel caused plaintiffs to suffer heart attacks, strokes, dangerous blood clots, heart failure and other life-threatening cardiovascular problems. The complaints further allege that the manufacturer of AndroGel engaged in aggressive marketing that encouraged men to seek treatment for low sex drive, fatigue and other symptoms merely associated with aging. The lawsuits attribute the rapid growth in the use of testosterone therapy to this so-called "disease mongering," and further claim that these tactics caused many men to be prescribed AndroGel in the absence of a true medical need.
In addition to AndroGel, court filings show that a number of testosterone lawsuits involving similar allegations are pending in courts around the county against the manufacturer of Testim. At least two such claims were filed this month in the U.S. District Court, Eastern District of Pennsylvania. (Case Nos. 140301684 and 140302537). A Testim lawsuit was filed in U.S. District Court, Northern District of California in February. (Case No. No. 14-278)
Men who allegedly suffered serious heart problems associated with AndroGel, Testim or another low testosterone therapy may be entitled to compensation for their injury-related damages. To learn more about the litigation involving testosterone lawsuits, please visit Bernstein Liebhard LLP’s website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since the list was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com